M&A

Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?
Motley Fool
Fri, 03/15/19 - 11:55 pm
M&A
Bristol-Myers Squibb
Celgene
CEO of Novartis’ generics unit quits, sparking sale speculation
Pharmaforum
Thu, 03/14/19 - 10:06 am
Novartis
Sandoz
generics
M&A
Richard Francis
biosimilars
Stryker pays up to $220m for OrthoSpace
Mass Device
Thu, 03/14/19 - 09:54 am
Stryker
OrthoSpace
M&A
devices
How This Looming Patent Battle Could Challenge Bristol-Celgene Deal
Investors Business Daily
Wed, 03/13/19 - 10:13 am
Celgene
Novartis
ozanimod
MS
multiple sclerosis
patents
Bristol-Myers Squibb
M&A
Bristol-Myers CEO Caforio wants M&A dissidents to know there's been no 'high level' overtures about buying the company since '17
Endpoints
Tue, 03/12/19 - 07:35 pm
Bristol-Myers Squibb
Celgene
Giovanni Caforio
M&A
Biotech execs predict big M&A deals ahead as mood shifts in wake of a 2018 hangover — Endpoints 100
Endpoints
Tue, 03/12/19 - 11:59 am
JPMHC 2020
biotech
drug pricing
M&A
Smith & Nephew puts up $660m for Osiris Therapeutics
Mass Device
Tue, 03/12/19 - 10:16 am
Smith & Nephew
Osiris Therapeutics
M&A
devices
Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business
Yahoo/Reuters
Tue, 03/12/19 - 10:08 am
Fujifilm
Biogen
M&A
Japan
biologics
Celgene Submits MS Drug for Approval in Europe, FDA Filing on Track
Xconomy
Mon, 03/11/19 - 10:25 pm
Celgene
Bristol-Myers Squibb
Europe
FDA
M&A
MS
multiple sclerosis
ozanimod
Does Bristol-Myers have a plan B if activists scuttle its Celgene buy?
Fierce Pharma
Mon, 03/11/19 - 10:09 pm
Bristol-Myers Squibb
Celgene
M&A
It’s what Bristol-Myers execs aren’t saying that makes one key analyst wonder about a potential buyout offer, looming Opdivo data and Plan B
Endpoints
Mon, 03/11/19 - 10:07 am
Bristol-Myers Squibb
Celgene
M&A
Opdivo
[video+transcript]Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?
Motley Fool
Sat, 03/9/19 - 12:11 pm
gene therapy
M&A
Rengexbio
Spark bidding war drove Roche bid up by $2.1 billion
BioCentury
Thu, 03/7/19 - 09:46 pm
Spark Therapeutics
Roche
M&A
Blood Giant Grifols Acquires $1.9 Billion Stake in Shanghai RAAS
Yahoo/Bloomberg
Thu, 03/7/19 - 09:37 am
Grifols
Shanghai RAAS
blood products
M&A
Bristol-Myers urges shareholders in open letter to support $74 billion Celgene deal amid resistance
CNBC
Wed, 03/6/19 - 09:53 am
Bristol-Myers Squibb
M&A
Celgene
Biogen to acquire ophthalmology gene therapy play Nightstar
BioCentury
Mon, 03/4/19 - 10:37 am
Biogen
M&A
Nightstar Therapeutics
gene therapy
ophthalmology
The Bristol-Myers–Squibb Deal May No Longer Be a Sure Thing, but It Will Still Likely Happen
Barron's
Sat, 03/2/19 - 12:39 pm
M&A
Bristol-Myers Squibb
Celgene
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington
Xconomy
Wed, 02/27/19 - 07:21 pm
Bristol-Myers Squibb
Celgene
M&A
Wellington
Gene Therapy Market Heats up as Sarepta Buys Myonexus for $165 Million
BioSpace
Wed, 02/27/19 - 10:57 am
Sarepta Therapeutics
gene therapy
M&A
Myonexus
GE selling off biopharma business in $21.4B deal
BioPharma Dive
Mon, 02/25/19 - 12:30 pm
GE Healthcare
M&A
Danaher

Pages